Results 271 to 280 of about 1,007,648 (393)
PERCUTANEOUS NEPHROLITHOTRIPSY
Shinichi Ohshima +10 more
openaire +3 more sources
Advances and Challenges in Micro/Nanocarrier‐Based Dermal Drug Delivery Systems for Acne Treatment
Topical acne treatment faces challenges from skin barriers and complex causes. Micro/nanocarriers improve drug delivery by enhancing bioavailability, targeting, and duration. Combining carriers creates synergistic effects for systematic intervention.
Jintao Yang +7 more
wiley +1 more source
This review highlights how autoimmune diseases arise from intertwined immunological, genetic, and environmental factors, emphasizing gut microbiota dysbiosis as a pivotal driver. It outlines emerging nanotechnology‐based strategies—such as liposomes, hydrogels, and polymeric nanoparticles—that enhance targeted drug delivery, minimize systemic toxicity,
Md. Meraj Ansari +5 more
wiley +1 more source
Endoscopic Ultrasound-Guided Tissue Acquisition for Diagnosing Hepatic Malignant Lymphoma. [PDF]
Takano Y +5 more
europepmc +1 more source
Percutaneous repair or surgery for mitral regurgitation.
Robert C Gorman +2 more
semanticscholar +1 more source
ABSTRACT Photocatalytic materials have emerged as promising solutions for environmental applications due to their ability to degrade organic pollutants under sunlight or artificial light. In this review, recent progress on the photocatalytic materials used for the degradation of pharmaceutical personal care products (PPCPs) in environmental ...
Urvashi Sen +5 more
wiley +1 more source
Percutaneous anterior talofibular ligament repair: A new technique for chronic ankle instability. [PDF]
Elalfy MM +4 more
europepmc +1 more source
Percutaneous Implantation of an Entirely Intracardiac Leadless Pacemaker.
Vivek Y. Reddy +14 more
semanticscholar +1 more source
Gene‐Specific Growth Charts for ASXL3‐Related Disorder
American Journal of Medical Genetics Part A, EarlyView.
E. Woods +3 more
wiley +1 more source
With multiple disease‐modifying therapies now available, treatment switching has become an important clinical consideration in the management of spinal muscular atrophy (SMA). While some switches are prompted by suboptimal clinical response, more commonly they are driven by treatment burden, convenience, or adverse events.
Andrej Belančić +4 more
wiley +1 more source

